JP2007502101A5 - - Google Patents

Info

Publication number

JP2007502101A5

JP2007502101A5 JP2006521226A JP2006521226A JP2007502101A5 JP 2007502101 A5 JP2007502101 A5 JP 2007502101A5 JP 2006521226 A JP2006521226 A JP 2006521226A JP 2006521226 A JP2006521226 A JP 2006521226A JP 2007502101 A5 JP2007502101 A5 JP 2007502101A5

Authority

JP

Japan

Prior art keywords

seq

polypeptide

acid sequence

amino acid

nucleic acid

Prior art date

2004-07-22

Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)

Pending

Links

• Espacenet
• Global Dossier
• Discuss

• 229920001184 polypeptide Polymers 0.000 claims 30
• 108090000765 processed proteins & peptides Proteins 0.000 claims 30
• 102000004196 processed proteins & peptides Human genes 0.000 claims 30
• 125000003275 alpha amino acid group Chemical group 0.000 claims 14
• 150000007523 nucleic acids Chemical class 0.000 claims 13
• 108020004707 nucleic acids Proteins 0.000 claims 11
• 102000039446 nucleic acids Human genes 0.000 claims 11
• 230000001681 protective effect Effects 0.000 claims 10
• 239000008194 pharmaceutical composition Substances 0.000 claims 9
• 108010076504 Protein Sorting Signals Proteins 0.000 claims 7
• 230000036039 immunity Effects 0.000 claims 7
• 230000002163 immunogen Effects 0.000 claims 7
• 238000000034 method Methods 0.000 claims 6
• 108090000623 proteins and genes Proteins 0.000 claims 6
• 240000004808 Saccharomyces cerevisiae Species 0.000 claims 4
• 210000002421 cell wall Anatomy 0.000 claims 4
• 239000012634 fragment Substances 0.000 claims 4
• 230000028993 immune response Effects 0.000 claims 4
• 230000001939 inductive effect Effects 0.000 claims 4
• 230000004807 localization Effects 0.000 claims 4
• 239000002773 nucleotide Substances 0.000 claims 4
• 125000003729 nucleotide group Chemical group 0.000 claims 4
• 210000004027 cell Anatomy 0.000 claims 3
• 208000015181 infectious disease Diseases 0.000 claims 3
• 239000000203 mixture Substances 0.000 claims 3
• 108020004705 Codon Proteins 0.000 claims 2
• 108091028043 Nucleic acid sequence Proteins 0.000 claims 2
• 210000004899 c-terminal region Anatomy 0.000 claims 2
• 239000013604 expression vector Substances 0.000 claims 2
• 238000004519 manufacturing process Methods 0.000 claims 2
• 210000005253 yeast cell Anatomy 0.000 claims 2
• FWMNVWWHGCHHJJ-SKKKGAJSSA-N 4-amino-1-[(2r)-6-amino-2-[[(2r)-2-[[(2r)-2-[[(2r)-2-amino-3-phenylpropanoyl]amino]-3-phenylpropanoyl]amino]-4-methylpentanoyl]amino]hexanoyl]piperidine-4-carboxylic acid Chemical compound C([C@H](C(=O)N[C@H](CC(C)C)C(=O)N[C@H](CCCCN)C(=O)N1CCC(N)(CC1)C(O)=O)NC(=O)[C@H](N)CC=1C=CC=CC=1)C1=CC=CC=C1 FWMNVWWHGCHHJJ-SKKKGAJSSA-N 0.000 claims 1
• 108091026890 Coding region Proteins 0.000 claims 1
• 239000002671 adjuvant Substances 0.000 claims 1
• 150000001413 amino acids Chemical class 0.000 claims 1
• 239000003937 drug carrier Substances 0.000 claims 1
• 125000002924 primary amino group Chemical group [H]N([H])* 0.000 claims 1
• 238000000746 purification Methods 0.000 claims 1
• 230000004044 response Effects 0.000 claims 1